These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 17657605)

  • 1. Perturbed nuclear receptor signaling by environmental obesogens as emerging factors in the obesity crisis.
    Grün F; Blumberg B
    Rev Endocr Metab Disord; 2007 Jun; 8(2):161-71. PubMed ID: 17657605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling.
    Grün F; Blumberg B
    Endocrinology; 2006 Jun; 147(6 Suppl):S50-5. PubMed ID: 16690801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesogens.
    Grün F
    Curr Opin Endocrinol Diabetes Obes; 2010 Oct; 17(5):453-9. PubMed ID: 20689419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The obesogen tributyltin.
    Grün F
    Vitam Horm; 2014; 94():277-325. PubMed ID: 24388195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental Obesogens: Mechanisms and Controversies.
    Heindel JJ; Blumberg B
    Annu Rev Pharmacol Toxicol; 2019 Jan; 59():89-106. PubMed ID: 30044726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity II: Establishing causal links between chemical exposures and obesity.
    Heindel JJ; Howard S; Agay-Shay K; Arrebola JP; Audouze K; Babin PJ; Barouki R; Bansal A; Blanc E; Cave MC; Chatterjee S; Chevalier N; Choudhury M; Collier D; Connolly L; Coumoul X; Garruti G; Gilbertson M; Hoepner LA; Holloway AC; Howell G; Kassotis CD; Kay MK; Kim MJ; Lagadic-Gossmann D; Langouet S; Legrand A; Li Z; Le Mentec H; Lind L; Monica Lind P; Lustig RH; Martin-Chouly C; Munic Kos V; Podechard N; Roepke TA; Sargis RM; Starling A; Tomlinson CR; Touma C; Vondracek J; Vom Saal F; Blumberg B
    Biochem Pharmacol; 2022 May; 199():115015. PubMed ID: 35395240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental models of developmental programming: consequences of exposure to an energy rich diet during development.
    Armitage JA; Taylor PD; Poston L
    J Physiol; 2005 May; 565(Pt 1):3-8. PubMed ID: 15695245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesogens in the aquatic environment: an evolutionary and toxicological perspective.
    Capitão A; Lyssimachou A; Castro LFC; Santos MM
    Environ Int; 2017 Sep; 106():153-169. PubMed ID: 28662399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tributyltin engages multiple nuclear receptor pathways and suppresses osteogenesis in bone marrow multipotent stromal cells.
    Baker AH; Watt J; Huang CK; Gerstenfeld LC; Schlezinger JJ
    Chem Res Toxicol; 2015 Jun; 28(6):1156-66. PubMed ID: 25932594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal muscle and nuclear hormone receptors: implications for cardiovascular and metabolic disease.
    Smith AG; Muscat GE
    Int J Biochem Cell Biol; 2005 Oct; 37(10):2047-63. PubMed ID: 15922648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental estrogens and obesity.
    Newbold RR; Padilla-Banks E; Jefferson WN
    Mol Cell Endocrinol; 2009 May; 304(1-2):84-9. PubMed ID: 19433252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine disruptors: from endocrine to metabolic disruption.
    Casals-Casas C; Desvergne B
    Annu Rev Physiol; 2011; 73():135-62. PubMed ID: 21054169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicogenomics in the 3T3-L1 cell line, a new approach for screening of obesogenic compounds.
    Pereira-Fernandes A; Vanparys C; Vergauwen L; Knapen D; Jorens PG; Blust R
    Toxicol Sci; 2014 Aug; 140(2):352-63. PubMed ID: 24848799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perinatal exposure to environmental estrogens and the development of obesity.
    Newbold RR; Padilla-Banks E; Snyder RJ; Jefferson WN
    Mol Nutr Food Res; 2007 Jul; 51(7):912-7. PubMed ID: 17604389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the Nrf2/Keap1 pathway in obesity and metabolic syndrome.
    Zhang Z; Zhou S; Jiang X; Wang YH; Li F; Wang YG; Zheng Y; Cai L
    Rev Endocr Metab Disord; 2015 Mar; 16(1):35-45. PubMed ID: 25540093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPARs and the complex journey to obesity.
    Evans RM; Barish GD; Wang YX
    Nat Med; 2004 Apr; 10(4):355-61. PubMed ID: 15057233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphenol A environmental exposure and the detrimental effects on human metabolic health: is it necessary to revise the risk assessment in vulnerable population?
    Valentino R; D'Esposito V; Ariemma F; Cimmino I; Beguinot F; Formisano P
    J Endocrinol Invest; 2016 Mar; 39(3):259-63. PubMed ID: 26105974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early programming of adipose tissue function: a large-animal perspective.
    Mostyn A; Symonds ME
    Proc Nutr Soc; 2009 Nov; 68(4):393-400. PubMed ID: 19719893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear receptors and the control of metabolism.
    Francis GA; Fayard E; Picard F; Auwerx J
    Annu Rev Physiol; 2003; 65():261-311. PubMed ID: 12518001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear receptors and their coregulators in kidney.
    Ruan XZ; Varghese Z; Powis SH; Moorhead JF
    Kidney Int; 2005 Dec; 68(6):2444-61. PubMed ID: 16316322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.